Amylyx Pharmaceuticals, Inc.
USD18.70
+0.91 (+5.12%)
CEO
Joshua Cohen
IPO Date
2022-01-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.66
Prev. Close
$17.79
Day Low
$17.46
Day High
$18.75
52W Low
$5.97
52W High
$18.75
Market Cap
$1.55B
Volume
2.33M
| 24,372 |
| $14.31 |
| 8 Jun 2026 | Quimi Daphne | director | A-Award | Acquired | 24,372 | $14.31 |
| 8 Jun 2026 | MILNE GEORGE M JR | director | A-Award | Acquired | 24,372 | $14.31 |
| 8 Jun 2026 | FONTEYNE PAUL R. | director | A-Award | Acquired | 24,372 | $14.31 |
| 26 May 2026 | Firestone Karen | director | P-Purchase | Acquired | 3,800 | $13.51 |
| 9 Mar 2026 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | A-Award | Acquired | 248,865 | $0.00 |
| 9 Mar 2026 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | A-Award | Acquired | 373,295 | $14.10 |
| 9 Mar 2026 | Mazzariello Gina | Chief Legal Officer | A-Award | Acquired | 74,660 | $0.00 |
| 9 Mar 2026 | Mazzariello Gina | Chief Legal Officer | A-Award | Acquired | 111,990 | $14.10 |